Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible <it>Staphylococcus aureus </it>bacteremia
<p>Abstract</p> <p>Background</p> <p>The high prevalence of methicillin-resistant <it>S. aureus </it>(MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infecti...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-10-01
|
| Series: | BMC Infectious Diseases |
| Online Access: | http://www.biomedcentral.com/1471-2334/11/279 |